Skin manifestations in vasculitis and erythema nodosum

Clinical and Experimental Rheumatology

Volumn 24, Issue SUPPL. 40, 2006, Pages

  Atzeni, F ^a   Carrabba, M ^a   Davin, J C ^b   Frances C ^b   Ferri, C ^c   Guillevin, L ^d   Jorizzo, J L ^e   Mascia, M T ^c   Patel, M J ^e   Pagnoux, C ^d   Vulpio, L ^a   Sarzi Puttini, Piercarlo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Université Paris 5 René Descartes ^*  (France)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Churg Strauss syndrome; Cutaneous vasculitis; Erythema nodosum; Polyarteritis nodosa; Urticarial vasculitis

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTIVIRUS AGENT; AZATHIOPRINE; CALCINEURIN INHIBITOR; CD20 ANTIBODY; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DAPSONE; HYDROXYCHLOROQUINE; HYDROXYCHLOROQUINE SULFATE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PEGINTERFERON; PENTOXIFYLLINE; POTASSIUM IODIDE; PREDNISONE; RIBAVIRIN; RITUXIMAB; STEROID; THALIDOMIDE; TRIAMCINOLONE;

ANAPHYLACTOID PURPURA; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; COMPRESSION THERAPY; CRYOGLOBULINEMIA; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE COURSE; DRUG INDICATION; ERYTHEMA NODOSUM; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; MICROSCOPIC POLYANGIITIS; PATHOGENESIS; PLASMAPHERESIS; POLYARTERITIS NODOSA; PRIORITY JOURNAL; PROGNOSIS; PURPURA; RELAPSE; RESPIRATORY TRACT INFECTION; REVIEW; RISK BENEFIT ANALYSIS; SKIN MANIFESTATION; SKIN TUBERCULOSIS; SMALL VESSEL VASCULITIS; STREPTOCOCCUS; SYSTEMIC VASCULITIS; UNSPECIFIED SIDE EFFECT; URTICARIA; VASCULITIS; WEGENER GRANULOMATOSIS;

CRYOGLOBULINEMIA; ERYTHEMA NODOSUM; HUMANS; PURPURA, SCHOENLEIN-HENOCH; SKIN DISEASES; VASCULITIS;

EID: 33645017604     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. GUILLEVIN L, LHOTE F, GHERARDI R: Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: clinical aspects, neurologic manifestations, and treatment. Neurol Clin 1997; 15: 865-86.
2. DIAZ-PEREZ JL, WINKELMANN RK: Cutaneous periarteritis nodosa. Arch Dermatol 1974; 110: 407-14.
3. GUILLEVIN L, COHEN P, GAYRAUD M, LHOTE F, JARROUSSE B, CASASSUS P: Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999; 78: 26-37.
4. DAVIS MD, DAOUD MS, MCEVOY MT, SU WP: Cutaneous manifestations of Churg-Strauss syndrome: a clinicopathologic correlation. J Am Acad Dermatol 1997; 37: 199-203.
5. FAUCI AS, HAYNES BF, KATZ P, WOLFF SM: Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98: 76-85.
6. HOFFMAN GS, KERR GS, LEAVITT RY et al.: Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488-98.
7. FRANCÈS C, LÊ THI HUONG D, PIETTE JC et al.: Wegener's granulomatosis. Dermatological manifestations in 75 cases with clinicopathologic correlation. Arch Dermatol 1994; 130: 861-7.
8. BARKSDALE SK, HALLAHAN CW, KERR GS, FAUCI AS, STERN JB, TRAVIS WD: Cutaneous pathology in Wegener's granulomatosis. A clinicopathologic study of 75 biopsies in 46 patients. Am J Surg Pathol 1995; 19: 161-72.
9. THOMAS-GOLBANOV C, SRIDHARAN S: Novel therapies in vasculitis. Expert Opin Investig Drugs 2001; 10: 1279-89.
10. JAYNE D: How to induce remission in primary systemic vasculitis. Best Pract Res Clin Rheumatol 2005; 19: 293-305.
11. EKENSTAM E, CALLEN JP: Cutaneous leukocytoclastic vasculitis. Clinical and laboratory features of 82 patients seen in private practice. Arch Dermatol 1984; 120: 484-9.
12. LOTTI T, COMACCHI C, GHERSETICH I: Cutaneous necrotizing vasculitis. Int J Dermatol 1996; 35: 457-74.
13. RESNICK AH, ESTERLY NB: Vasculitis in children. Int J Dermatol 1985; 24: 139-46.
14. LYNCH PJ: Vascular reactions. In: SCHACHNER LA, HANSEN RC (Eds.): Pediatric Dermatology. New York, Churchill Livingstone, 1988: 959-1014.
15. LOTTI T, GHERSETICH I, COMACCHI C, JORIZZO JL: Cutaneous small-vessel vasculitis. J Am Acad Dermatol 1998; 39: 667-87.
16. JORIZZO JL, SOLOMON AR, ZANOLLI MD, LESHIN B: Neutrophilic vascular reactions. J Am Acad Dermatol 1988; 19:983-1005.
17. MACKEL SE, TAPPEINER G, BRUMFIELD H, JORDAN RE: Circulating immune complexes in cutaneous vasculitis. Detection with C1q and monoclonal rheumatoid factor. J Clin Invest 1979; 64: 1652-60.
18. MACKEL SE, JORDON RE: Leukocytoclastic vasculitis. A cutaneous expression of immune complex disease. Arch Dermatol 1982; 118: 296-301.
19. BARHAM KL, JORIZZO JL, GRATTAN B, COX NH: Vasculitis and neutrophilic vascular reactions. In: BURNS T, BREATHNACH S, COX N, GRIFFITHS C (Eds.): Rook's Textbook of Dermatology. Oxford, Blackwell Publishing, 2004: 49.1-49.46.
20. NURNBERG W, GRABBE J, CZARNETZKI BM: Urticarial vasculitis syndrome effectively treated with dapsone and pentoxifylline. Acta Derm Venereol 1995; 75: 54-6.
21. JENNETTE JC, FALK RJ, ANDRASSY K et al.: Nomenclature of systemic vasculitides. Proposal of an International Consensus Conference. Arthritis Rheum 1994; 37: 187-94.
22. DAVIN JC, TEN BERGHE I, WEENING JJ: Henoch-Schönlein purpura nephritis and IgA nephropathy: what makes the difference? Kidney Int 2001; 59: 823-31.
23. DOLEZALOVA P, TELEKESOVA P, NEMCOVAD et al.: Incidence of vasculitis in children in the Czech Republic: 2-year prospective epidemiology survey. J Rheumatol 2004; 31: 2295-301.
24. YANG YH, HUNG CF, HSU CR: A nationwide survey on epidemiological characteristics of childhood Henoch-Schonlein purpura in Taiwan. Rheumatology 2005; 44: 618-24.
25. WATTS RA, CARRUTHERS DM, SCOTT DG: Epidemiology of systemic vasculitis: changing incidence or definition? Semin Arthritis Rheum 1995; 25: 28-31.
26. VERNIER RL, FARQUHAR MG, BRUNSON JG et al.: Anaphylactoid purpura I. Pathology of the skin and kidney and frequency of streptococcal infections. Pediatrics 1961; 27: 181-7.
27. EMANCIPATOR SN: Primary and secondary forms of IgA nephritis and Schönlein-Henoch syndrome. In: HEPTINSHALL RH (Eds.): Pathology of the Kidney. Toronto, London, Little, Brown, 1993: 389-411.
28. DE FIJTER JW, EIJGERAAM JW, BRAAM C et al.: Deficient IgA1 immune response to nasal cholera toxin subunit B in primary IgA nephropathy. Kidney Int 1996: 50; 952-59.
29. HAYCOCK GB: The nephritits of Henoch-Schönlein purpura. In: CAMERSON S, DAVISON AM, GRÜNFELD J-P, KERR D, RITZ E (Eds.): Oxford Textbook of Clinical Nephrology. Oxford New York Tokyo. Oxford University Press, 1992: 595-607.
30. WHITE RHR, YOSHIKAWA N: Henoch-Schönlein nephritis. In: BARRAT TM, HOLIDAY M (Eds.): Pediatric Nephrology. Baltimore, Williams & Wilkins, 1993: 729-37.
31. BROYER M: Fréquence et cause de l'insuffisance rénale chez l'enfant. In: ROYER P, HABIB R, MATTHIEU H, BROYER M (Eds.): Néphrologie Pédiatrique. Paris, Flammarion Médecine-Sciences,1983: 425-6.
32. GOLDSTEIN AR, WHITE RHR, AKUSE R et al.: Long term follow-up of childhood Henoch-Schönlein nephritis. Lancet 1992; 339: 280.
33. GOREVIC PD, FRANGIONE B: Mixed cryoglobulinemia cross-reactive idiotypes: implication for relationship of MC to rheumatic and lymphoproliferative diseases. Semin Hematol 1991; 28: 79-94.
34. DAMMACCO F, SANSONNO D, PICCOLI C et al.: The cryoglobulins: an overview. Eur J Clin Invest 2001; 31: 628-38.
35. FERRI C, ZIGNEGO AL, PILERI SA: Cryoglobulins. J Clin Pathol 2002; 55: 4-13.
36. ABEL G, ZHANG QX, AGNELLO V: Hepatitis C virus infection in type 11 mixed cryoglobulinemia. Arthritis Rheum 1993; 36: 1341-9.
37. FERRI C, SEBASTIANI M, GIUGGIOLI D et al.: Mixed cryoglobulinemia: demographic, clinical, and serological features, and survival in 231 patients. Sem Arthritis Rheum 2004; 33: 355-74.
38. FERRI C, MASCIA MT: Cryoglobulinemic vasculitis. Curr Opin Rheumatol 2006: in press.
39. ANTONELLI A, FERRI C, FALLAHI P et al.: Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia. QJM 2004; 97: 499-506.
40. ANTONELLI A, FERRI C, FALLAHI P et al.: Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients. Rheumatology (Oxford) 2004; 43: 238-40.
41. FERRI C, BERTOZZI MA, ZIGNEGO AL: Erectile dysfunction and HCV infection. JAMA 2002; 14: 698-9.
42. FERRI C, GIUGGIOLI D, CAZZATO M et al.: HCV-related cryoglobulinemic vasculitis: an update on its etiopathogenesis and therapeutic strategies. Clin Exp Rheumatol 2003; 21: S78-84.
43. REQUENA L, REQUENA C: Erythema nodosum. Dermatol Online J 2002; 8 1.
44. VESEY CMR, WILKINSON DS: Erythema nodosum. Br J Dermatol 1959; 71: 139-55.
45. KAKOUROU T, DROSATOU P, PSYCHOU F et al.: Erythema nodosum in children. J Am Acad Dermatol 2001; 44: 17-21.
46. GARCIA-PORRUA C, GONZALEZ-GAY MA, VAZQUEZ-CARUNCHO M et al.: Erythema nodosum. Etiologic and predictive factors in defined population. Arthritis Rheum 2000; 43: 584-92.
47. MIESCHER G: Zur Histologic des erythema nodosum. Acta Derm Venereol (Stockh) 1947; 27: 447-68.
48. HEDFORS E, NORBERG R: Evidence for circulating immune complexes in sarcoidosis. Clin Exp Dermatol 1974; 16: 493-6.
49. GONZALEZ-GAY MA, GARCIA-PORRUA C, SALVARANI C, LO SCOCCO G, PUJOL RM: Cutaneous vasculitis: a diagnostic approach. Clin Exp Rheumatol 2003; 21 (Suppl. 32): S85-S88.
50. LOFGREN S: Primary pulmonary sarcoidosis. Acta Med Scand 1953; 145: 424-31
51. REQUENA L, SANCHEZ YUS E: Panniculitis. Part II. Mostly lobular panniculitis. J Am Acad Dermatol 2001; 45: 325-61.
52. DINC A, BAYIR A, SIMSEK I, ERDEM H, PAY S, TURAN M: The proportional Venn diagram of Beheet's disease-related manifestations among young adult men in Turkey. Clin Exp Rheumatol 2005; 23 (Suppl. 38): S86-S90.
53. PIPITONE N, BOIARDI L, OLIVIERI I et al.: Clinical manifestations of Behqet's disease in 137 Italian patients: results of a multicenter study. Clin Exp Rheumatol 2004; 22 (Suppl. 36): S46-S51.
54. AMOLI MM, LLORCA J, GOMEZ-GIGIREY A et al.: E-selectin polymorphism in erythema nodosum secondary to sarcoidosis. Clin Exp Rheumatol 2004; 22: 230-2.
55. REQUENA L, SANCHEZ YUS E: Panniculitis. Part I. Mostly septal panniculitis. J Am Acad Dermatol 2001; 45: 163-83.
56. HORIO T, IMAMURA S, DANNO K et al.: Potassium iodide in the treatment of erythema nodosum and nodular vasculitis. Arch Dermatol 1981; 117: 29-31.